glp 1 agonist metformin Comparing Glucagon‐like peptide‐1 receptor agonists versus in drug‐naive patients: A nationwide cohort study Metformin and Glucagon-like peptide-1 (GLP-1)
Description
Calcif Tissue Int (2015) 97(5):50615.10.1007/s00223-015-0037-y 22 MabilleauGMieczkowskaAChappardD
8.1 Standardization and digital integration in diagnosis Recent estimates of prevalence and misclassification have resulted from differing criteria for the diagnosis of PDM
Copyright HAPPIEST HEALTH SYSTEMS PRIVATE LIMITED
The decision to initiate GLP-1 therapy should always be based on primary indicationstype 2 diabetes management or weight management in obesitywith lipid improvements considered a valuable secondary benefit
Crit Rev Ther Drug Carrier Syst
